The global market for Mesenchymal Stem Cell Therapy(MSCT) was valued at US$ 1185 million in the year 2024 and is projected to reach a revised size of US$ 2856 million by 2031, growing at a CAGR of 13.6% during the forecast period.
Mesenchymal stem cell therapy (MSCT) involves extracting a sample of MSCs from a patient鈥檚 blood stream or bone marrow, multiplying them once in the lab, and then reintroducing the multiplied cells back into their blood or spinal cord fluid, via infusion.
North American market for Mesenchymal Stem Cell Therapy(MSCT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mesenchymal Stem Cell Therapy(MSCT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Mesenchymal Stem Cell Therapy(MSCT) in Cancer Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Mesenchymal Stem Cell Therapy(MSCT) include Biotherapy International, Mesoblast, Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd, Cellular Biomedicine Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cell Therapy(MSCT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cell Therapy(MSCT).
The Mesenchymal Stem Cell Therapy(MSCT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesenchymal Stem Cell Therapy(MSCT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesenchymal Stem Cell Therapy(MSCT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Biotherapy International
Mesoblast
Tianjin Angsai Cell Genetic Engineering Co. Ltd
Qingdao Aoke Biological Development Co. Ltd
Beijing Beilai Biotechnology Co. Ltd
Shanghai Aisar Biotechnology Co. Ltd
Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
Beijing Han's United Biotechnology Co. Ltd
Bosheng Excellence Biotechnology (Beijing) Co. Ltd
Cellular Biomedicine Group
Guangzhou Celera Stem Cell Technology Co. Ltd.
Stem Med Pte Ltd
CryoCord Sdn Bhd
Cytopeutics Sdn Bhd
Stempeutics Research Pvt Ltd
Segment by Type
Treatment Service
Medication
Segment by Application
Cancer Therapy
Inflammatory
Fibrotic Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesenchymal Stem Cell Therapy(MSCT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Treatment Service
1.2.3 Medication
1.3 麻豆原创 by Application
1.3.1 Global Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Therapy
1.3.3 Inflammatory
1.3.4 Fibrotic Diseases
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Perspective (2020-2031)
2.2 Global Mesenchymal Stem Cell Therapy(MSCT) Growth Trends by Region
2.2.1 Global Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mesenchymal Stem Cell Therapy(MSCT) Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Mesenchymal Stem Cell Therapy(MSCT) Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Dynamics
2.3.1 Mesenchymal Stem Cell Therapy(MSCT) Industry Trends
2.3.2 Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Drivers
2.3.3 Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Challenges
2.3.4 Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mesenchymal Stem Cell Therapy(MSCT) Players by Revenue
3.1.1 Global Top Mesenchymal Stem Cell Therapy(MSCT) Players by Revenue (2020-2025)
3.1.2 Global Mesenchymal Stem Cell Therapy(MSCT) Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Mesenchymal Stem Cell Therapy(MSCT) Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mesenchymal Stem Cell Therapy(MSCT) Revenue
3.4 Global Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Concentration Ratio
3.4.1 Global Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cell Therapy(MSCT) Revenue in 2024
3.5 Global Key Players of Mesenchymal Stem Cell Therapy(MSCT) Head office and Area Served
3.6 Global Key Players of Mesenchymal Stem Cell Therapy(MSCT), Product and Application
3.7 Global Key Players of Mesenchymal Stem Cell Therapy(MSCT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mesenchymal Stem Cell Therapy(MSCT) Breakdown Data by Type
4.1 Global Mesenchymal Stem Cell Therapy(MSCT) Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Mesenchymal Stem Cell Therapy(MSCT) Forecasted 麻豆原创 Size by Type (2026-2031)
5 Mesenchymal Stem Cell Therapy(MSCT) Breakdown Data by Application
5.1 Global Mesenchymal Stem Cell Therapy(MSCT) Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Mesenchymal Stem Cell Therapy(MSCT) Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size (2020-2031)
6.2 North America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2020-2025)
6.4 North America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size (2020-2031)
7.2 Europe Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2020-2025)
7.4 Europe Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size (2020-2031)
9.2 Latin America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Mesenchymal Stem Cell Therapy(MSCT) 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biotherapy International
11.1.1 Biotherapy International Company Details
11.1.2 Biotherapy International Business Overview
11.1.3 Biotherapy International Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.1.4 Biotherapy International Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.1.5 Biotherapy International Recent Development
11.2 Mesoblast
11.2.1 Mesoblast Company Details
11.2.2 Mesoblast Business Overview
11.2.3 Mesoblast Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.2.4 Mesoblast Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.2.5 Mesoblast Recent Development
11.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd
11.3.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Details
11.3.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview
11.3.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.3.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.3.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development
11.4 Qingdao Aoke Biological Development Co. Ltd
11.4.1 Qingdao Aoke Biological Development Co. Ltd Company Details
11.4.2 Qingdao Aoke Biological Development Co. Ltd Business Overview
11.4.3 Qingdao Aoke Biological Development Co. Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.4.4 Qingdao Aoke Biological Development Co. Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.4.5 Qingdao Aoke Biological Development Co. Ltd Recent Development
11.5 Beijing Beilai Biotechnology Co. Ltd
11.5.1 Beijing Beilai Biotechnology Co. Ltd Company Details
11.5.2 Beijing Beilai Biotechnology Co. Ltd Business Overview
11.5.3 Beijing Beilai Biotechnology Co. Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.5.4 Beijing Beilai Biotechnology Co. Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.5.5 Beijing Beilai Biotechnology Co. Ltd Recent Development
11.6 Shanghai Aisar Biotechnology Co. Ltd
11.6.1 Shanghai Aisar Biotechnology Co. Ltd Company Details
11.6.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview
11.6.3 Shanghai Aisar Biotechnology Co. Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.6.4 Shanghai Aisar Biotechnology Co. Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.6.5 Shanghai Aisar Biotechnology Co. Ltd Recent Development
11.7 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
11.7.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Details
11.7.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
11.7.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.7.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.7.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development
11.8 Beijing Han's United Biotechnology Co. Ltd
11.8.1 Beijing Han's United Biotechnology Co. Ltd Company Details
11.8.2 Beijing Han's United Biotechnology Co. Ltd Business Overview
11.8.3 Beijing Han's United Biotechnology Co. Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.8.4 Beijing Han's United Biotechnology Co. Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.8.5 Beijing Han's United Biotechnology Co. Ltd Recent Development
11.9 Bosheng Excellence Biotechnology (Beijing) Co. Ltd
11.9.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Details
11.9.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
11.9.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.9.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.9.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development
11.10 Cellular Biomedicine Group
11.10.1 Cellular Biomedicine Group Company Details
11.10.2 Cellular Biomedicine Group Business Overview
11.10.3 Cellular Biomedicine Group Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.10.4 Cellular Biomedicine Group Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.10.5 Cellular Biomedicine Group Recent Development
11.11 Guangzhou Celera Stem Cell Technology Co. Ltd.
11.11.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Company Details
11.11.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
11.11.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.11.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.11.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development
11.12 Stem Med Pte Ltd
11.12.1 Stem Med Pte Ltd Company Details
11.12.2 Stem Med Pte Ltd Business Overview
11.12.3 Stem Med Pte Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.12.4 Stem Med Pte Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.12.5 Stem Med Pte Ltd Recent Development
11.13 CryoCord Sdn Bhd
11.13.1 CryoCord Sdn Bhd Company Details
11.13.2 CryoCord Sdn Bhd Business Overview
11.13.3 CryoCord Sdn Bhd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.13.4 CryoCord Sdn Bhd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.13.5 CryoCord Sdn Bhd Recent Development
11.14 Cytopeutics Sdn Bhd
11.14.1 Cytopeutics Sdn Bhd Company Details
11.14.2 Cytopeutics Sdn Bhd Business Overview
11.14.3 Cytopeutics Sdn Bhd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.14.4 Cytopeutics Sdn Bhd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.14.5 Cytopeutics Sdn Bhd Recent Development
11.15 Stempeutics Research Pvt Ltd
11.15.1 Stempeutics Research Pvt Ltd Company Details
11.15.2 Stempeutics Research Pvt Ltd Business Overview
11.15.3 Stempeutics Research Pvt Ltd Mesenchymal Stem Cell Therapy(MSCT) Introduction
11.15.4 Stempeutics Research Pvt Ltd Revenue in Mesenchymal Stem Cell Therapy(MSCT) Business (2020-2025)
11.15.5 Stempeutics Research Pvt Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Biotherapy International
Mesoblast
Tianjin Angsai Cell Genetic Engineering Co. Ltd
Qingdao Aoke Biological Development Co. Ltd
Beijing Beilai Biotechnology Co. Ltd
Shanghai Aisar Biotechnology Co. Ltd
Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
Beijing Han's United Biotechnology Co. Ltd
Bosheng Excellence Biotechnology (Beijing) Co. Ltd
Cellular Biomedicine Group
Guangzhou Celera Stem Cell Technology Co. Ltd.
Stem Med Pte Ltd
CryoCord Sdn Bhd
Cytopeutics Sdn Bhd
Stempeutics Research Pvt Ltd
听
听
*If Applicable.
